Ambroxol (Portuguese Wikipedia)
Analysis of information sources in references of the Wikipedia article "Ambroxol" in Portuguese language version.
refsWebsite
Global rank
Portuguese rank
low place
6,695th place
low place
low place
621st place
1,847th place
low place
low place
5,225th place
low place
low place
low place
ache.com.br (Global: low place; Portuguese: 6,695th place)
- Aché Laboratórios Farmacêuticos S.A. «Bula do medicamento» (PDF). Consultado em 10 de maio de 2023
clinicaltrials.gov (Global: 5,225th place; Portuguese: low place)
beta.clinicaltrials.gov
- Ambroxol to Slow Progression in Parkinson Disease (ASPro-PD). ClinicalTrials.gov
doi.org (Global: 2nd place; Portuguese: 4th place)
dx.doi.org
- Seifart C, Clostermann U, Seifart U, Müller B, Vogelmeier C, von Wichert P, Fehrenbach H (fevereiro de 2005). «Cell-specific modulation of surfactant proteins by ambroxol treatment». Toxicology and Applied Pharmacology. 203 (1): 27–35. PMID 15694461. doi:10.1016/j.taap.2004.07.015
- Fois G, Hobi N, Felder E, Ziegler A, Miklavc P, Walther P, Radermacher P, Haller T, Dietl P (dezembro de 2015). «A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca2+ release from acidic Ca2+ stores». Cell Calcium. 58 (6): 628–37. PMID 26560688. doi:10.1016/j.ceca.2015.10.002
- Sanderson RJ, Paul GW, Vatter AE, Filley GF (setembro de 1976). «Morphological and physical basis for lung surfactant action». Respiration Physiology. 27 (3): 379–92. PMID 989610. doi:10.1016/0034-5687(76)90066-9
- Kido H, Okumura Y, Yamada H, Mizuno D, Higashi Y, Yano M (novembro de 2004). «Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential». Biological Chemistry. 385 (11): 1029- 34. PMID 15576322. doi:10.1515/BC.2004.133
- Weiser T (março de 2006). «Comparison of the effects of four Na+ channel analgesics on TTX-resistant Na+ currents in rat sensory neurons and recombinant Nav1. 2 recombinante». Neuroscience Letters. 395 (3): 179-84. PMID 16293367. doi:10.1016/j.neulet.2005.10.058
- de Mey C, et al. (2008), «Efficacy and safety of ambroxol lozenges in the treatment of acute uncomplicated sore throat», Arzneimittelforschung, 58 (11): 557–68, PMID 19137906, doi:10.1055/s-0031-1296557
- McNeill A, Magalhaes J, Shen C, Chau KY, Hughes D, Mehta A, Foltynie T, Cooper JM, Abramov AY, Gegg M, Schapira AH (maio de 2014). «Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells». Brain. 137 (Pt 5): 1481–95. PMC 3999713
. PMID 24574503. doi:10.1093/brain/awu020
ichgcp.net (Global: low place; Portuguese: low place)
- Terapia com ambroxol para pacientes com doença de Gaucher tipo 1 e resposta abaixo do ideal à terapia de reposição enzimática ichgcp.net, 12 de fevereiro de 2023.
nih.gov (Global: 4th place; Portuguese: 8th place)
ncbi.nlm.nih.gov
- Seifart C, Clostermann U, Seifart U, Müller B, Vogelmeier C, von Wichert P, Fehrenbach H (fevereiro de 2005). «Cell-specific modulation of surfactant proteins by ambroxol treatment». Toxicology and Applied Pharmacology. 203 (1): 27–35. PMID 15694461. doi:10.1016/j.taap.2004.07.015
- Fois G, Hobi N, Felder E, Ziegler A, Miklavc P, Walther P, Radermacher P, Haller T, Dietl P (dezembro de 2015). «A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca2+ release from acidic Ca2+ stores». Cell Calcium. 58 (6): 628–37. PMID 26560688. doi:10.1016/j.ceca.2015.10.002
- Sanderson RJ, Paul GW, Vatter AE, Filley GF (setembro de 1976). «Morphological and physical basis for lung surfactant action». Respiration Physiology. 27 (3): 379–92. PMID 989610. doi:10.1016/0034-5687(76)90066-9
- Kido H, Okumura Y, Yamada H, Mizuno D, Higashi Y, Yano M (novembro de 2004). «Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential». Biological Chemistry. 385 (11): 1029- 34. PMID 15576322. doi:10.1515/BC.2004.133
- Weiser T (março de 2006). «Comparison of the effects of four Na+ channel analgesics on TTX-resistant Na+ currents in rat sensory neurons and recombinant Nav1. 2 recombinante». Neuroscience Letters. 395 (3): 179-84. PMID 16293367. doi:10.1016/j.neulet.2005.10.058
- de Mey C, et al. (2008), «Efficacy and safety of ambroxol lozenges in the treatment of acute uncomplicated sore throat», Arzneimittelforschung, 58 (11): 557–68, PMID 19137906, doi:10.1055/s-0031-1296557
- McNeill A, Magalhaes J, Shen C, Chau KY, Hughes D, Mehta A, Foltynie T, Cooper JM, Abramov AY, Gegg M, Schapira AH (maio de 2014). «Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells». Brain. 137 (Pt 5): 1481–95. PMC 3999713. PMID 24574503. doi:10.1093/brain/awu020
sonoticiaboa.com.br (Global: low place; Portuguese: low place)
- Parkinson: remédio para tosse entra na 3ª fase de testes com bons resultados. Por Renata Giraldi sonoticiaboa.com.br 19 de janeiro de 2023
stn-international.de (Global: low place; Portuguese: low place)
- Sample Search for Ambroxol in einer Präsentation zur STN-Version von "Pharmaceutical Substances" (englisch).
ucl.ac.uk (Global: 1,306th place; Portuguese: 1,471st place)
zenodo.org (Global: 621st place; Portuguese: 1,847th place)
- Kido H, Okumura Y, Yamada H, Mizuno D, Higashi Y, Yano M (novembro de 2004). «Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential». Biological Chemistry. 385 (11): 1029- 34. PMID 15576322. doi:10.1515/BC.2004.133